Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HI-COR-65: Intravenous Iron for Quality of Life in Elderly Patients With Acute Coronary Syndrome
NCT07476859Phase 4Recruiting
- Sponsor
- INCLIVA Biomedical Research Institute
- Start
- Mar 2026
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by INCLIVA Biomedical Research Institute. Started Mar 2026; status: recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT07476859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07476859.